A Study of Replagal in Children and Adults With Fabry Disease in India — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Replagal in Children and Adults With Fabry Disease in India — Stella

Recruiting

Back to Fabry Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(3 sites)

India

Institute of Child Health, Kolkata

All India Institute of Medical Sciences (AIIMS), New Delhi

Sir Gangaram Hospital, New Delhi

Key details

Phase

Post-approval study

Sponsor

Shire

Collaborators

Takeda

Enrollment target

~5 participants

Started

November 2022

Primary completion

October 2026

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov